Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients After Assessment of Health Literacy Level
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Renal Dialysis
- Sponsor
- Centre Hospitalier de Vichy
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Level of understanding and treatment management
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to learn if an intervention of a hospital pharmacist could help, dialysis patients managed his treatment. In a first time, the health literacy level will be assed.
The main questions it aims to answer are:
What is the impact of the clinical pharmacist intervention on the understanding level and management level of his treatment by the patient? Does the intervention of the pharmacist has an effect on the biologicals parameters of the patient? Researchers will compare a group with a pharmacist intervention VS a group without pharmacist intervention for dialysis patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient over 18 years of age
- •On dialysis (peritoneal dialysis, hemodialysis) for at least 3 months
- •Prescription for at least 5 daily medications
- •Patient who has not received any pharmaceutical consultation from a hospital pharmacist as part of his or her treatment for chronic renal failure.
Exclusion Criteria
- •Patient does not speak and/or understand French
- •Patient's cognitive state does not permit an interview
- •Patient not autonomous in managing his or her daily medication (e.g.: patient in nursing home)
- •Patient refusal
Outcomes
Primary Outcomes
Level of understanding and treatment management
Time Frame: 12 months
Assessment of level of understanding and management of treatment using a survey based on the questionnaire validated by the French Health Authority (HAS). In order to take better account of the diversity of treatments for dialysis patients, we will use an adaptation of this questionnaire describing more precisely the patient's knowledge of treatments related to phosphocalcic metabolism and potassium. A score of 7 on this questionnaire means an excellent understanding of the treatment A score of 0 on this questionnaire means the poorest understanding of the treatment
Secondary Outcomes
- Phosphatemia evolution(12 months)
- Calcemia evolution(12 months)
- PTH evolution(12 months)
- Vitamine D evolution(12 months)
- Quality of life(12 months)
- Assessment of compliance with medication(12 months)
- level of health literacy(12 months)
- Assessment of patient-reported compliance with medication(12 months)
- Kalemia evolution(12 months)